You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Liver conditions
  5. Chronic liver disease

LIVERFASt for assessing and monitoring liver fibrosis, activity and steatosis

  • Medtech innovation briefing
  • Reference number: MIB317
  • Published:  21 February 2023

Download (PDF)
  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Expert commentators
  • Development of this briefing

Regulatory information

LIVERFASt is a CE-marked class IVD general in vitro diagnostic medical device under the EU In Vitro Diagnostic Medical Devices Directive (IVDD).


Next page Equality considerations Previous page The technology
Back to top